Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California. Show more
333 South Grand Avenue, Los Angeles, CA, 90071, United States
Market Cap
259.6M
52 Wk Range
$10.04 - $10.74
Previous Close
$10.56
Open
$10.60
Volume
7,322
Day Range
$10.56 - $10.60
Enterprise Value
258.2M
Cash
1.435M
Avg Qtr Burn
-143.9K
Insider Ownership
0.00%
Institutional Own.
90.40%
Qtr Updated
12/31/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
